On March 20, Gelonghui Pharmaceutical (301075.SZ) announced that in order to enrich the production platform for pharmaceutical intermediates and APIs and further improve the company's industrial chain layout, Tibet Dorui Pharmaceutical Co., Ltd. plans to sign a “Contract for Investment in the Construction of Pharmaceutical Ingredients and Intermediates Projects” with the Yicheng Municipal People's Government. The project is located in the Xiangyang (Yicheng) Fine Chemical Industrial Park and covers an area of 128 acres. The details are as specified in the state-owned land use rights concession contract.

The project aims to make full use of the location advantages of Yicheng Fine Chemical Park, rely on the existing foundation of the subsidiary Hubei Xinchengda Chemical Co., Ltd., enrich the production platform for pharmaceutical intermediates and APIs, and further improve the company's industrial chain layout.